Ning Xi

5PUBLICATIONS
12CO-AUTHORS
Molecular targetsNonlinear optics and spectroscopyCheminformatics and quantitative structure-activity relationshipsF-block chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 22, 2026
Structure-Based Drug Discovery of Triazine Derivatives as Potent and Orally Bioavailable AXL Inhibitors for Cancer Therapy.

|Nov 23, 2022
Effects of fluorine bonding and nonbonding interactions on 19F chemical shifts.

Yang Lu, Mingming Sun, Ning Xi

|Nov 03, 2022
Structure-based discovery of potent inhibitors of Axl: design, synthesis, and biological evaluation.

Shuang Wu, Min Liao, Minxiong Li

|Oct 24, 2020
Drug interaction of ningetinib and gefitinib involving CYP1A1 and efflux transporters in non-small cell lung cancer patients.

Lu Liu, Qian Wang, Cen Xie

|Sep 06, 2018
Noncovalent Interactions of Fluorine with Amide and CH2 Groups in N-Phenyl γ-Lactams: Covalently Identical Fluorine Atoms in Nonequivalent Chemical Environments.

Ning Xi, Xiaohua Sun, Minxiong Li

Pageof 1

Frequent Collaborators

1 joint publications

Xu Bai

1 joint publications

Lu Liu

1 joint publications

Qian Wang

1 joint publications

Ming Li